Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testingBusiness Overview: SPL is a is WHO-GMP certified integrated manufacturer of formulations like tablet, capsules and small volume parenteral. It has assisted in the development and manufacture of a variety of drugs and dosage forms and potency variations for...
Shukra Pharmaceuticals has published advertisements regarding its postal ballot notice, informing shareholders about resolutions requiring their approval via remote e-voting. Electronic copies of the notice have been sent to registered email addresses. Voting eligibility is determined by shares held as of a specified cut-off date. The e-voting window is open...
Shukra Pharmaceuticals shared that recent media coverage highlighted its successful listing on the National Stock Exchange (NSE). This marks a key milestone, as the company's shares are now traded on both BSE and NSE. The articles also discuss the company's strategic vision for future growth, emphasizing Medical Technology, Artificial Intelligence,...
Shukra Pharmaceuticals has entered into a Term Sheet with Borns Medical Robotics Pte Ltd, Singapore, to establish a strategic joint venture. This new entity, B&S Robotics Private Limited, will focus on designing, manufacturing, distributing, and servicing AI-enabled surgical robotic systems across India and the Asia-Pacific region. Shukra will hold a...
Shukra Pharmaceuticals has approved a proposal to change its name to Shukra Medtech Limited and expand its main business objectives to include the medical technology sector. This strategic move aims to broaden the company's corporate identity and enable it to pursue new opportunities in MedTech, covering development, manufacturing, and distribution...
Shukra Pharmaceuticals' equity shares have been successfully listed and admitted for trading on the National Stock Exchange of India Limited (NSE) Main Board under the symbol SHUKRAPHAR. This dual-listing is a significant step for the company, aimed at enhancing share liquidity, broadening its investor base, and increasing stakeholder value. The...
